Literature DB >> 2675859

Endothelin is a potent mitogen for rat vascular smooth muscle cells.

Y Hirata1, Y Takagi, Y Fukuda, F Marumo.   

Abstract

The effect of endothelin (ET), a novel endothelium-derived vasoconstrictive peptide, on DNA synthesis was studied in cultured rat vascular smooth muscle cells (VSMC). ET stimulated incorporation of [3H]thymidine into DNA of the quiescent VSMC in a dose-dependent manner; the approximate half-maximal and maximal stimulation for DNA synthesis was induced with 2 x 10(-10) M and 10(-9) M, respectively. The stimulatory effect by ET on DNA synthesis was completely inhibited by the calcium channel blocker nifedipine. ET combined with epidermal growth factor and transforming growth factor-alpha, but not with platelet-derived growth factor, had synergistic effects. These data indicate that ET is a potent mitogen as well as a constrictor for VSMC, suggesting its potential role in the development of vascular disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675859     DOI: 10.1016/0021-9150(89)90227-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  57 in total

Review 1.  Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction.

Authors:  G Burnstock
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

2.  Plasma endothelin-1 levels in Behçet's disease.

Authors:  T Uslu; C Erem; M Tosun; O Deger
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 3.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

4.  NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.

Authors:  Sergio de Frutos; Elizabeth Caldwell; Carlos H Nitta; Nancy L Kanagy; Jian Wang; Wei Wang; Mary K Walker; Laura V Gonzalez Bosc
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-21       Impact factor: 4.733

5.  Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease.

Authors:  M Donatelli; E Hoffmann; I Colletti; G Andolina; V Russo; M L Bucalo; T M Valenti; V Compagno; M G Cataldo; M L Morici
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

6.  Ultrastructural localisation of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury.

Authors:  A Loesch; P Milner; S C Anglin; R Crowe; S Miah; J R McEwan; G Burnstock
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

7.  Endothelin-1 in idiopathic pulmonary fibrosis.

Authors:  M Uguccioni; L Pulsatelli; B Grigolo; A Facchini; L Fasano; C Cinti; M Fabbri; G Gasbarrini; R Meliconi
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

8.  Localisation of endothelin like immunoreactivity in adult and developing human gut.

Authors:  C Escrig; A E Bishop; H Inagaki; G Moscoso; K Takahashi; I M Varndell; M A Ghatei; S R Bloom; J M Polak
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 9.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

10.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

Authors:  H Ito; Y Hirata; S Adachi; M Tanaka; M Tsujino; A Koike; A Nogami; F Murumo; M Hiroe
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.